Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinlong Yang

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Breast Cancer Research : BCR|June 10, 2026
Targeting drug resistance in breast cancer: a dual-perspective landscape analysis of PROTACs from bench to bedsideYinlong Yang, Yihao Lin
British Journal of Haematology|May 12, 2010
Bilateral primary adrenal lymphomaYinlong Yang, Quan Li, Yifei Pan
Oncology Letters|February 15, 2014
Aggressive angiomyxoma of the thigh: A case report and review of the literatureXinying Liu, Xinghua Li, Yinlong Yang
Breast Cancer Research and Treatment|September 23, 2021
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016Yinlong Yang, Liangwei Pan, Zhiming Shao
BMC Women'S Health|April 2, 2025
Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancerQiuyan Huang, Qingzhong Lin, Yinlong Yang
Cancer Metastasis Reviews|October 22, 2014
MTA family of proteins in DNA damage response: mechanistic insights and potential applicationsDa-Qiang Li, Yinlong Yang, Rakesh Kumar
Breast Cancer Research and Treatment|June 7, 2019
Is core needle biopsy effective at diagnosing male breast lesions?Yinlong Yang, Shiping Li, Guangyu Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 26, 2014
Prognostic role of circulating microRNA-21 in cancers: evidence from a meta-analysisYinlong Yang, Jinxian Qian, Yizuo Chen, et al.
Breast (Edinburgh, Scotland)|September 24, 2025
Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysisYinlong Yang, Liangwei Pan, Wenzhe Zhou, et al.
Therapeutic Advances in Medical Oncology|September 29, 2025
Platelet-to-lymphocyte ratio as a prognostic biomarker in patients with human epidermal growth factor receptor 2-negative breast cancer undergoing taxane-carboplatin-based neoadjuvant chemotherapyQiuyan Huang, Kai Huang, Jinxian Qian, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research : BCR|June 10, 2026
Targeting drug resistance in breast cancer: a dual-perspective landscape analysis of PROTACs from bench to bedsideYinlong Yang, Yihao Lin
British Journal of Haematology|May 12, 2010
Bilateral primary adrenal lymphomaYinlong Yang, Quan Li, Yifei Pan
Oncology Letters|February 15, 2014
Aggressive angiomyxoma of the thigh: A case report and review of the literatureXinying Liu, Xinghua Li, Yinlong Yang
Breast Cancer Research and Treatment|September 23, 2021
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016Yinlong Yang, Liangwei Pan, Zhiming Shao
BMC Women'S Health|April 2, 2025
Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancerQiuyan Huang, Qingzhong Lin, Yinlong Yang
Cancer Metastasis Reviews|October 22, 2014
MTA family of proteins in DNA damage response: mechanistic insights and potential applicationsDa-Qiang Li, Yinlong Yang, Rakesh Kumar
Breast Cancer Research and Treatment|June 7, 2019
Is core needle biopsy effective at diagnosing male breast lesions?Yinlong Yang, Shiping Li, Guangyu Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 26, 2014
Prognostic role of circulating microRNA-21 in cancers: evidence from a meta-analysisYinlong Yang, Jinxian Qian, Yizuo Chen, et al.
Breast (Edinburgh, Scotland)|September 24, 2025
Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysisYinlong Yang, Liangwei Pan, Wenzhe Zhou, et al.
Therapeutic Advances in Medical Oncology|September 29, 2025
Platelet-to-lymphocyte ratio as a prognostic biomarker in patients with human epidermal growth factor receptor 2-negative breast cancer undergoing taxane-carboplatin-based neoadjuvant chemotherapyQiuyan Huang, Kai Huang, Jinxian Qian, et al.
Pageof 5